A.P. Moller-Maersk (Maersk) has signed a cold chain logistics agreement with pharmaceutical company Novo Nordisk that will cover ocean and inland transportation.
Novo Nordisk said in a statement that it has chosen Maersk’s ECO delivery to reduce the carbon footprint in transportation. The initiative uses sustainable biofuel to power selected Maersk-vessels and helps Novo Nordisk towards its sustainability goals.
The global agreement will enter effect on 1 April 2021.
Vincent Clerc, Executive Vice President and CEO Ocean and Logistics. A.P. Moller – Maersk, said,
“We are proud to be chosen as one of Novo Nordisk´s main logistic companies.
“Transporting pharmaceuticals on a global level is a demanding task with various complexities that require flexible and resilient supply chains as well as digital and eco-friendly solutions.
“This achievement showcases the rapid transformation of A.P. Moller – Maersk as a modern end-to-end logistics company with fully controlled assets
Rune Sylow, Corporate Vice President, Strategic Sourcing at Novo Nordisk, also commented, “Our ambition of achieving zero environmental impact is a cornerstone of our aspiration to be a truly sustainable business.
“We consider A.P. Moller – Maersk to be the right global distribution partner to secure the steady, environmentally friendly delivery of our high-value shipments and we look forward to the collaboration.
